Identification of NanoLuciferase Substrates Transported by Human ABCB1 and ABCG2 and Their Zebrafish Homologs at the Blood-Brain Barrier
John A. Quinlan(National Cancer Institute), Michael M. Gottesman(National Institutes of Health)
Cited by 2
Related Papers
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
|Pharmacological Reviews|2012|968
Overlapping Substrate and Inhibitor Specificity of Human and Murine ABCG2
|Drug Metabolism and Disposition|2013|49
<b>Regulation and Expression of the ATP-Binding Cassette Transporter</b> ABCG2 <b>in Human Embryonic Stem Cells</b>
|Stem Cells|2012|37
A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy
|Molecular Pharmacology|2015|25
Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrier
|Scientific Reports|2016|10